DR. MARTIN D. WELTZ, D.O.

GREENBELT, MD

Research Active
Internal Medicine - Hematology & Oncology NPI registered 21+ years 1 publication 1982 – 1982 NPI: 1740283100
AspirinBlood PlateletsColonic NeoplasmsRectal NeoplasmsPatient ComplianceActuarial AnalysisAdjuvants, Pharmaceutic

Practice Location

7525 GREENWAY CENTER DR
GREENBELT, MD 20770-3525

Phone: (301) 982-9800

What does MARTIN WELTZ research?

Dr. Weltz studies colorectal cancer, particularly the effectiveness of treatments designed to prevent the disease from returning after surgery. One of his main areas of research involves the use of aspirin, a common medication often taken to reduce blood clots, to see if it might also help cancer patients. His findings are important for patients with colon or rectal cancer, as they indicate the limitations of aspirin in enhancing survival or preventing cancer spread after surgical interventions.

Key findings

  • In a study with 66 patients, no difference in survival rates or cancer recurrence was observed between those taking aspirin and those who did not after two years.
  • Aspirin was shown to be ineffective in preventing the recurrence of colorectal cancer in the surgical setting.
  • The research clarifies that regular doses of aspirin do not provide any additional benefit for those recovering from surgery for advanced colon or rectal cancer.

Frequently asked questions

Does Dr. Weltz study colorectal cancer?
Yes, Dr. Weltz specifically focuses on colorectal cancer and treatments to prevent its recurrence.
What treatments has Dr. Weltz researched?
Dr. Weltz has researched the use of aspirin as a treatment to prevent the return of colorectal cancer after surgery.
Is Dr. Weltz's work relevant to patients with advanced colon cancer?
Yes, his findings are particularly relevant to patients with advanced colon cancer as they clarify the ineffectiveness of aspirin in their treatment.

Publications in plain English

Adjuvant antiplatelet therapy with aspirin in colo-rectal cancer.

1982

Journal of medicine

Lipton A, Scialla S, Harvey H, Dixon R, Gordon R +5 more

Plain English
This study looked at 66 patients with advanced colon or rectal cancer to see if taking aspirin would help prevent the cancer from coming back after surgery. After two years, the researchers found that there was no difference in survival rates or cancer recurrence between those who took aspirin and those who did not. This shows that regular doses of aspirin do not help prevent spread of colorectal cancer following surgery. Who this helps: This helps patients with colon or rectal cancer, as it clarifies that aspirin is not an effective treatment for preventing cancer recurrence.

PubMed

Frequent Co-Authors

A Lipton S Scialla H Harvey R Dixon R Gordon R Hamilton H Ramsey R Heckard D White

Physician data sourced from the NPPES NPI Registry . Publication data from PubMed . Plain-English summaries generated by AI. Not medical advice.